Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing Type
3
Filing Date
3/3/2019
Updated
3/4/19, 11:12 AM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership